Equillium Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 55.78% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.6%	Decheng Capital LLC	4,447,308	€3.1m	0%	0.69%
10.5%	Bruce Steel	3,711,995	€2.6m	0%	no data
6.54%	Biocon Limited	2,316,134	€1.6m	0%	no data
5.29%	Daniel Bradbury	1,873,307	€1.3m	0%	no data
5.2%	Takeda Ventures, Inc.	1,842,977	€1.3m	0%	49.9%
5.19%	BioBrit, LLC	1,838,688	€1.3m	0%	no data
2.8%	Stephen Connelly	993,000	€701.0k	0%	no data
2.38%	The Vanguard Group, Inc.	841,948	€594.4k	0%	no data
1.59%	Cota Capital Management LLC	562,278	€396.9k	0%	1.27%
0.91%	Renaissance Technologies LLC	321,173	€226.7k	6.92%	no data
0.58%	Geode Capital Management, LLC	204,385	€144.3k	-5.47%	no data
0.38%	Christine Zedelmayer	135,246	€95.5k	0%	no data
0.34%	Jason Keyes	121,633	€85.9k	-7.6%	no data
0.31%	Acadian Asset Management LLC	108,691	€76.7k	0%	no data
0.28%	Callan Capital, LLC	99,688	€70.4k	0%	no data
0.17%	State Street Global Advisors, Inc.	59,720	€42.2k	0%	no data
0.16%	Joel Rothman	58,150	€41.1k	0%	no data
0.11%	BlackRock, Inc.	40,165	€28.4k	4.82%	no data
0.099%	Northern Trust Global Investments	35,019	€24.7k	0%	no data
0.093%	Dcf Advisers, Llc	32,962	€23.3k	0%	0.01%
0.071%	Commonwealth Equity Services, LLC	25,000	€17.6k	0%	no data
0.067%	Martha Demski	23,799	€16.8k	0%	no data
0.067%	Bala Manian	23,799	€16.8k	0%	no data
0.067%	Mark Pruzanski	23,799	€16.8k	0%	no data
0.067%	Charles McDermott	23,799	€16.8k	0%	no data